Bavarian drug gets European recommendation
A small pox vaccine from Bavarian Nordic has received a positive recommendation from the EMA advisory committee, CHMP. The Danish company expects a final decision in the near future.
by Stefan Singh Kailay
The EMA advisory panel, CHMP, gave a positive recommendation of Bavarian Nordic’s small pox vaccine, Imvanex, late last week, the company has announced in a stock market release.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
